SINTX TECHNOLOGIES, INC Net Income 2012-2024 | SINT

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

SINTX TECHNOLOGIES, INC net income from 2012 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.

SINTX TECHNOLOGIES, INC Net Income 2012-2024 | SINT

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

SINTX TECHNOLOGIES, INC net income from 2012 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$233.1B
Intuitive Surgical (ISRG)	$171.3B
Alcon (ALC)	$47.7B
IQVIA Holdings (IQV)	$44.2B
IDEXX Laboratories (IDXX)	$42.1B
Edwards Lifesciences (EW)	$40.7B
DexCom (DXCM)	$27.8B
STERIS (STE)	$23.5B
SONOVA HOLDING (SONVY)	$20.8B
Waters (WAT)	$19.8B
Hologic (HOLX)	$19B
Sysmex ADR (SSMXY)	$12.3B
Fresenius Medical Care AG KGaA (FMS)	$12.2B
Teleflex (TFX)	$11.4B
Globus Medical (GMED)	$9.4B
Penumbra (PEN)	$7.6B
Glaukos (GKOS)	$6.7B
Masimo (MASI)	$6.1B
TransMedics (TMDX)	$5.2B
PROCEPT BioRobotics (PRCT)	$4.3B
Integer Holdings (ITGR)	$4.3B
Tandem Diabetes Care (TNDM)	$2.8B
LivaNova (LIVN)	$2.8B
Veracyte (VCYT)	$2.6B
Inari Medical (NARI)	$2.6B
Elekta AB (EKTAY)	$2.6B
Nihon Kohden (NHNKY)	$2.5B
RxSight (RXST)	$2B
Integra LifeSciences Holdings (IART)	$1.4B
Pulse Biosciences (PLSE)	$1.2B